Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
Horm Cancer 3: 147-159, 2012
Murakami KI, Kaji T, Shimono R, Hyashida Y, Matsufuji H, Tsuyama S,
Maezono R, Kosai K, Takamatsu H.
Therapeutic effects of vitamin A on experimental cholestatic rats with
hepatic fibrosis.
Pediatr Surg Int. 27(8):863-70, 2011
Shigekawa T, Ijichi N, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.
Horm Cancer. 2: 286-297. 2011
Subcategories
業績
論文掲載「Translational Research」川上広高、伊地知暢広、小濵祐行、松田恵理子、三井薫、西川路侑耶、渡邉真希、永野聡、谷口昂、小宮節朗、小戝健一郎
『An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy』がTransl Res. 2024 Jul 3:S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002.に掲載されました。
Transl Res. 2024 Jul 3:S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002.
